| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2011 | CA2463506C Synthesis of (4-bromophenyl) (4-piperidyl)methanone-(z)-o-ethyloxime and salts |
| 01/04/2011 | CA2463259C Chewable tablet containing lysine |
| 01/04/2011 | CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/04/2011 | CA2460920C Stent coated with a sustained-release drug delivery and method for use thereof |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
| 01/04/2011 | CA2456901C Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity |
| 01/04/2011 | CA2455933C Soluble roasted chicory having high inulin content |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2451393C 2 pyrrolidone derivatives as prostanoid agonists |
| 01/04/2011 | CA2451241C Unsymmetrical cyclic diamine compound |
| 01/04/2011 | CA2451238C Cyclic diamine compound with 5 membered ring groups |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2447335C Targeted delivery of drugs for the treatment of viral infections |
| 01/04/2011 | CA2446828C Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 01/04/2011 | CA2445251C Crystalline form of omeprazole |
| 01/04/2011 | CA2444569C A novel coating for a sustained release pharmaceutical composition |
| 01/04/2011 | CA2443728C Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 01/04/2011 | CA2435908C Aromatic derivatives as hiv aspartyl protease inhibitors |
| 01/04/2011 | CA2430279C Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence |
| 01/04/2011 | CA2429486C O/w emulsion composition and method of preparing the same |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2427750C Substituted alkanoic acids |
| 01/04/2011 | CA2421228C Polyarylcarboxamides useful as lipid lowering agents |
| 01/04/2011 | CA2416803C Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 01/04/2011 | CA2416274C N-phenyl-2-pyrimidine-amine derivatives |
| 01/04/2011 | CA2415275C Improved methods of synthesis for 9-substituted hypoxanthine derivatives |
| 01/04/2011 | CA2413426C Methods and compositions utilizing quinazolinones |
| 01/04/2011 | CA2412941C Piperidine compounds for use as ccr-3 inhibitors |
| 01/04/2011 | CA2412932C Pleuromutilin derivatives having antibacterial activity |
| 01/04/2011 | CA2408754C Delivery devices for treatment of vascular disease |
| 01/04/2011 | CA2405371C Active substance combinations with insecticidal and acaricidal properties |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2400959C Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 |
| 01/04/2011 | CA2397798C Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 01/04/2011 | CA2396554C Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 01/04/2011 | CA2396165C Airway alkalinization as therapy for airway diseases |
| 01/04/2011 | CA2389544C Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 01/04/2011 | CA2389206C Activation of hcv-specific t cells |
| 01/04/2011 | CA2388609C Oxcarbazepine formulations for administration with or without food |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2382848C Diagnostics and therapeutics for osteoporosis |
| 01/04/2011 | CA2380370C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/04/2011 | CA2379909C Drug releasing biodegradable fiber implant |
| 01/04/2011 | CA2375008C Phenoxypropylamine compounds |
| 01/04/2011 | CA2369694C Agent for improving ketosis |
| 01/04/2011 | CA2365085C Therapeutic agents for diabetes |
| 01/04/2011 | CA2360451C N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance |
| 01/04/2011 | CA2352005C Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| 01/04/2011 | CA2350127C Avipox vector coding an hiv antigen and a cytokine |
| 01/04/2011 | CA2335702C Hydrophilic polymer blends used to prevent cow skin infections |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 01/04/2011 | CA2317505C Enzyme catalyzed therapeutic agents |
| 01/04/2011 | CA2306875C Nutritional supplement for cerebral metabolic insufficiencies |
| 01/04/2011 | CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 01/04/2011 | CA2303343C C-c chemokine production inhibitor |
| 01/04/2011 | CA2303338C Water soluble paclitaxel derivatives |
| 01/04/2011 | CA2281272C 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives and a process for preparation thereof |
| 01/04/2011 | CA2268865C Anti-p53 single-chain antibody fragments and their uses |
| 01/04/2011 | CA2248869C Allele suppression |
| 01/04/2011 | CA2246744C Immunomodulatory complex and use thereof in diseases caused by helicobacter |
| 01/04/2011 | CA2239208C Treatment and diagnosis of infections due to helicobacter pylori |
| 01/04/2011 | CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/04/2011 | CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them |
| 01/04/2011 | CA2217191C Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent |
| 01/04/2011 | CA2198376C Hydroxycitric acid concentrate and method of making |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/02/2011 | CA2708919A1 Gymnemic acids for antifungal applications |
| 01/02/2011 | CA2671067A1 Gymnemic acids for antifungal applications |
| 12/30/2010 | US20100333216 Non-human gene-disrupted animal with disrupted Adam11 gene |
| 12/30/2010 | US20100332417 Methods for the detection and quantitation of the p95 component of her2/neu (erbb2) |
| 12/30/2010 | US20100331999 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331819 Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy |
| 12/30/2010 | US20100331816 Rapamycin coated expandable devices |
| 12/30/2010 | US20100331812 Pharmaceutical Formulations for Iontophoretic Delivery of an Immunomodulator |
| 12/30/2010 | US20100331746 Method of using enoxaparin for reducing the risk of death in acutely ill medical patients |
| 12/30/2010 | US20100331611 Embryo implantation |
| 12/30/2010 | US20100331554 Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 12/30/2010 | US20100331551 Alpha-haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom |
| 12/30/2010 | US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions |
| 12/30/2010 | US20100331535 Conjugates and compositions for cellular delivery |
| 12/30/2010 | US20100331489 Branched water-soluble polymers and their conjugates |
| 12/30/2010 | US20100331425 Tapentadol for Treating Pain due to Osteoarthritis |
| 12/30/2010 | US20100331424 Use of Axomadol for Treatment of Arthrosis Pain |
| 12/30/2010 | US20100331423 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 12/30/2010 | US20100331422 Stable hydroalcoholic compositions |
| 12/30/2010 | US20100331421 Disinfectant and/or bactericidal aqueous compositions |
| 12/30/2010 | US20100331420 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331419 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331418 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal |
| 12/30/2010 | US20100331417 Treatment of neural diseases or conditions |
| 12/30/2010 | US20100331416 Use of Monochlorourea to Treat Industrial Waters |
| 12/30/2010 | US20100331415 Use of omega-3-fatty acid(s) |
| 12/30/2010 | US20100331414 Crystal comprising (2r)-2-propyloctanoic acid and amine |
| 12/30/2010 | US20100331413 Therapeutic Formulations Based on Asiatic Acid and Selected Salts Thereof |
| 12/30/2010 | US20100331412 Two container skin care product |
| 12/30/2010 | US20100331410 Biaryl Amides |
| 12/30/2010 | US20100331409 Use of Methyl Cinnamate in the Inhibition of Candida Albicans Biofilms |
| 12/30/2010 | US20100331407 Clear ophthalmic solution comprising latanoprost as active ingredient |